Found 8 matching trials
Exploratory Clinical Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of Tumor Neoantigen-pulsed Autologous Dendritic Cell Injection (YS247, Beijing YSCell Biotech Co., Ltd. [Abbreviated as YS])in Patients With Recurrent or Progressive Glioblastoma NA This is a single-center, open-label, dose-escalation, multiple-dose investi...
Show More Location
Multiple Locations
Learn More & Join Trial
Breast Cancer Neoantigen Vaccination With Autologous Dendritic Cells PHASE1 In this project, the investigators propose the first clinical study in Colo...
Show More Location
Universidad Nacional de Colombia
Learn More & Join Trial
Personalized Vaccine for TNBC Immunotherapy PHASE1 Due to their genetic instability, breast tumors that do not express recepto...
Show More Location
Facultad de Medicina - Universidad Nacional de Colombia
Learn More & Join Trial
Safety & Efficacy of DC Vaccine and TMZ for the Treatment of Newly-diagnosed Glioblastoma After Surgery PHASE1 This is a single-center, single-arm phase I study to determine the safety a...
Show More Location
Beijing Tiantan Hospital
Learn More & Join Trial
Personalized Neoantigen-pulsed Autologous Dendritic Cell Injections for Malignant Solid Tumors NA This is a prospective, single-center, open-label, real-world clinical study...
Show More Location
Beidaihe Hospital of Qinhuangdao
Learn More & Join Trial
YS247 (Neoantigen-Pulsed DC Vaccine) for Metastatic Prostate Cancer PHASE1 This phase I study tests a personalized cancer vaccine (Neo-DC) for men wit...
Show More Status
Enrolling By Invitation
Location
Shanghai Changhai Hospital
Learn More & Join Trial
A Translational Study of Tumor Antigen-pulsed DC Vaccine for ESCC PHASE1 The aim of this single center, single arm and prospective study is to explo...
Show More Location
West China Hospital
Learn More & Join Trial
Neoantigen-Pulsed Autologous Dendritic Cell Vaccine Combined With Temozolomide for Newly Diagnosed Glioblastoma PHASE2 This is a multicenter, open-label, randomized Phase II clinical study desig...
Show More Location
Multiple Locations
Learn More & Join Trial